HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mary Carrington Selected Research
Mary Carrington Research Topics
Disease
67
Infections
04/2024 - 05/2002
23
Acquired Immunodeficiency Syndrome (AIDS)
01/2024 - 01/2002
23
Viremia
12/2023 - 09/2006
21
Neoplasms (Cancer)
01/2024 - 04/2002
20
Disease Progression
01/2019 - 10/2006
18
HIV Infections (HIV Infection)
05/2024 - 05/2006
9
Virus Diseases (Viral Diseases)
01/2017 - 08/2002
6
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 06/2007
5
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2024 - 11/2007
4
COVID-19
01/2022 - 01/2021
4
Communicable Diseases (Infectious Diseases)
12/2021 - 01/2003
3
Disease Susceptibility (Diathesis)
01/2023 - 04/2015
3
Nasopharyngeal Carcinoma
01/2012 - 11/2005
3
Myositis (Idiopathic Inflammatory Myopathies)
11/2006 - 11/2005
2
Head and Neck Neoplasms (Head and Neck Cancer)
01/2024 - 01/2021
2
Liver Diseases (Liver Disease)
10/2023 - 06/2011
2
Inflammation (Inflammations)
10/2023 - 10/2020
2
Urinary Bladder Neoplasms (Bladder Cancer)
12/2022 - 01/2022
2
Hepatitis C
01/2022 - 06/2009
2
Malaria
01/2022 - 12/2017
2
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 02/2012
2
Kaposi Sarcoma (Kaposi's Sarcoma)
11/2019 - 02/2016
2
Persistent Infection
01/2018 - 06/2012
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 06/2010
2
Hypersensitivity (Allergy)
01/2017 - 03/2011
2
Crohn Disease (Crohn's Disease)
12/2013 - 04/2013
2
Chronic Hepatitis B
06/2012 - 11/2003
2
Hepatitis B
06/2012 - 12/2008
2
Polymyositis
11/2006 - 11/2005
2
Dermatomyositis (Dermatopolymyositis)
11/2006 - 11/2005
2
Psoriatic Arthritis
10/2004 - 09/2002
1
Burkitt Lymphoma (Burkitt's Lymphoma)
01/2024
1
Sclerosing Cholangitis
10/2023
1
Pathologic Constriction (Stenosis)
10/2023
1
Ulcerative Colitis
10/2023
1
Glioma (Gliomas)
01/2023
1
Rhabdomyosarcoma
01/2023
1
Lung Neoplasms (Lung Cancer)
01/2023
1
Ewing Sarcoma (Sarcoma, Ewing)
01/2023
1
Osteosarcoma (Osteogenic Sarcoma)
01/2023
Drug/Important Bio-Agent (IBA)
29
HLA-B Antigens (HLA-B)
IBA
05/2024 - 08/2002
28
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2024 - 04/2002
22
Ligands
IBA
04/2024 - 05/2002
18
Epitopes
IBA
01/2024 - 10/2006
18
Peptides (Polypeptides)
IBA
11/2023 - 11/2005
16
HLA-C Antigens (HLA-C)
IBA
01/2021 - 09/2002
14
Proteins (Proteins, Gene)
FDA Link
02/2023 - 01/2003
12
RNA (Ribonucleic Acid)
IBA
01/2024 - 06/2007
11
Antiviral Agents (Antivirals)
IBA
04/2024 - 09/2002
11
Vaccines
IBA
01/2022 - 05/2008
10
HLA-A Antigens (HLA-A)
IBA
01/2024 - 10/2004
10
KIR Receptors
IBA
01/2021 - 04/2005
7
DNA (Deoxyribonucleic Acid)
IBA
01/2024 - 01/2014
7
Antigens
IBA
01/2023 - 05/2006
6
Natural Killer Cell Receptors
IBA
10/2023 - 08/2004
6
Interferons
IBA
01/2022 - 09/2006
6
Immunoglobulins (Immunoglobulin)
IBA
02/2016 - 05/2002
4
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
11/2023 - 10/2006
4
tapasin
IBA
11/2023 - 06/2014
4
HLA-DP Antigens (HLA-DP)
IBA
10/2023 - 06/2012
4
Messenger RNA (mRNA)
IBA
01/2022 - 07/2010
4
Cytokines
IBA
01/2022 - 08/2002
4
HLA-B57 antigen
IBA
01/2018 - 02/2011
3
Histocompatibility Antigens Class I
IBA
01/2023 - 03/2007
3
Amino Acids
FDA Link
01/2022 - 12/2010
3
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2004
3
HLA-DPB1 antigen (HLA DPB1)
IBA
01/2020 - 06/2012
3
Interferon-gamma (Interferon, gamma)
IBA
11/2014 - 06/2012
3
HLA-DRB1 Chains (HLA DRB1)
IBA
07/2013 - 03/2006
3
Chemokines
IBA
11/2010 - 05/2009
3
Chemokine Receptors
IBA
01/2007 - 01/2002
2
Histocompatibility Antigens Class II
IBA
01/2023 - 01/2008
2
transporter associated with antigen processing (TAP)
IBA
01/2023 - 05/2003
2
HLA-DR Antigens (HLA-DR)
IBA
01/2023 - 01/2002
2
Broadly Neutralizing Antibodies
IBA
12/2019 - 12/2015
2
Membrane Proteins (Integral Membrane Proteins)
IBA
01/2017 - 06/2012
2
MicroRNAs (MicroRNA)
IBA
12/2016 - 01/2014
2
Enzymes
IBA
11/2014 - 11/2014
2
Codon (Codons)
IBA
08/2014 - 08/2009
2
3' Untranslated Regions (3' UTR)
IBA
12/2013 - 06/2012
2
HLA-DRB1*03:01 antigen
IBA
07/2013 - 11/2006
2
HLA-Bw4 antigen
IBA
06/2011 - 08/2007
2
Antigen Receptors (Antigen Receptor)
IBA
05/2009 - 05/2009
2
DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)
IBA
11/2007 - 12/2004
2
C-Type Lectins (C-Type Lectin)
IBA
11/2007 - 12/2004
2
Isoleucine (L-Isoleucine)
FDA Link
08/2007 - 08/2002
2
Autoantibodies
IBA
11/2006 - 03/2006
1
HLA-DPA1 antigen (HLA DPA1)
IBA
10/2023
1
Retinoic Acid Receptors (Retinoic Acid Receptor)
IBA
01/2023
1
Interleukin-13
IBA
01/2023
1
Interleukin-5 (Interleukin 5)
IBA
01/2023
Therapy/Procedure
15
Therapeutics
01/2024 - 10/2007
5
Transplantation
01/2022 - 12/2014
3
Immunotherapy
01/2024 - 12/2022
3
Art Therapy
12/2023 - 09/2014
3
Highly Active Antiretroviral Therapy (HAART)
03/2023 - 09/2006
3
Cell Transplantation
01/2020 - 01/2020
2
Precision Medicine
01/2023 - 12/2021
2
Aftercare (After-Treatment)
02/2022 - 01/2022
1
Liver Transplantation
10/2023